These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28085527)

  • 1. A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt.
    Elzomor H; Taha H; Nour R; Aleieldin A; Zaghloul MS; Qaddoumi I; Alfaar AS
    Ophthalmic Genet; 2017; 38(4):345-351. PubMed ID: 28085527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socioeconomic and psychological impact of treatment for unilateral intraocular retinoblastoma.
    Soliman SE; Dimaras H; Souka AA; Ashry MH; Gallie BL
    J Fr Ophtalmol; 2015 Jun; 38(6):550-8. PubMed ID: 25982424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America.
    Luna-Fineman S; Chantada G; Alejos A; Amador G; Barnoya M; Castellanos ME; Fu L; Fuentes-Alabi S; Girón V; Goenz MA; Maldonado C; Méndez G; Morales RA; Ortiz R; Sanchez G; Wilson M; Rodríguez-Galindo C
    J Clin Oncol; 2019 Nov; 37(31):2875-2882. PubMed ID: 31536438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
    Zhao J; Dimaras H; Massey C; Xu X; Huang D; Li B; Chan HS; Gallie BL
    J Clin Oncol; 2011 Mar; 29(7):845-51. PubMed ID: 21282531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Intra- and Extraocular Retinoblastomas from a Single Institute in South India.
    Shah PK; Narendran V; Kalpana N
    Ophthalmic Genet; 2015; 36(3):248-50. PubMed ID: 24372404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009).
    Lumbroso-Le Rouic L; Savignoni A; Levy-Gabriel C; Aerts I; Cassoux N; Salviat F; Gauthier-Villars M; Freneaux P; Brisse H; Dendale R; Esteve M; Doz F; Desjardins L
    J Fr Ophtalmol; 2015 Jun; 38(6):535-41. PubMed ID: 25976136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.
    Brennan RC; Qaddoumi I; Billups CA; Free TL; Haik BG; Rodriguez-Galindo C; Wilson MW
    Br J Ophthalmol; 2015 Oct; 99(10):1366-71. PubMed ID: 25873648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.
    Yannuzzi NA; Francis JH; Marr BP; Belinsky I; Dunkel IJ; Gobin YP; Abramson DH
    JAMA Ophthalmol; 2015 Sep; 133(9):1062-6. PubMed ID: 26181236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic retinoblastoma clinical features, treatment, and prognosis.
    Gündüz K; Müftüoglu O; Günalp I; Unal E; Taçyildiz N
    Ophthalmology; 2006 Sep; 113(9):1558-66. PubMed ID: 16828510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a formal program for retinoblastoma: Feasibility of clinical coordination across borders and impact on outcome.
    Al-Haddad C; Bashour Z; Farah L; Bayram L; Merabe Z; Ma'luf R; Alameddine R; Eid T; Geara F; Wilson M; Brennan R; Jeha S; Ghanem K; Yousef RA; Farah R; Noun P; Yassine N; Inati A; Muwakkit S; Abboud M; Tarek N; Hamideh D; Saab R
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27959. PubMed ID: 31423715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eye-Preserving Therapies for Advanced Retinoblastoma: A Multicenter Cohort of 1678 Patients in China.
    Zhou C; Wen X; Ding Y; Ding J; Jin M; Liu Z; Wang S; Han M; Yuan H; Xiao Y; Wu L; Wang J; Li Y; Yu J; Wen Y; Ye J; Liu R; Chen Z; Xue S; Lu W; Liao H; Cui J; Zhu D; Lu F; Tang S; Wu Y; Yangkyi T; Zhang G; Wubuli M; Guo H; Wang X; He Y; Sheng X; Wang Q; Luo Y; Fan J; Qi J; Yu Z; Tan J; Liang J; Sun X; Jin L; Yang X; Zhang J; Ji X; Zhao J; Jia R; Fan X
    Ophthalmology; 2022 Feb; 129(2):209-219. PubMed ID: 34536465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of chemoreduction for conservative therapy for retinoblastoma in Argentina.
    Chantada GL; Fandiño AC; Schvartzman E; Raslawski E; Schaiquevich P; Manzitti J
    Pediatr Blood Cancer; 2014 May; 61(5):821-6. PubMed ID: 24243706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoblastoma in Victoria, 1976-2000: changing management trends and outcomes.
    Dondey JC; Staffieri S; McKenzie J; Davie G; Elder J
    Clin Exp Ophthalmol; 2004 Aug; 32(4):354-9. PubMed ID: 15281966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-Arterial Chemotherapy for Retinoblastoma: A Single-Center Experience.
    Akyüz C; Kıratlı H; Şen H; Aydın B; Tarlan B; Varan A
    Ophthalmologica; 2015; 234(4):227-32. PubMed ID: 26368674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PREDICTIVE VALUE OF TNM CLASSIFICATION, INTERNATIONAL CLASSIFICATION, AND REESE-ELLSWORTH STAGING OF RETINOBLASTOMA FOR THE LIKELIHOOD OF HIGH-RISK PATHOLOGIC FEATURES.
    Yousef YA; Al-Hussaini M; Mehyar M; Sultan I; Jaradat I; AlRawashdeh K; Khurma S; Deebajah R; Nawaiseh I
    Retina; 2015 Sep; 35(9):1883-9. PubMed ID: 25923953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of therapy refusal against medical advice in retinoblastoma patients in a setting where treatment delays are common.
    Sitorus RS; Moll AC; Suhardjono S; Simangunsong LS; Riono P; Imhof S; Völker-Dieben HJ
    Ophthalmic Genet; 2009 Mar; 30(1):31-6. PubMed ID: 19172508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoblastoma: treatment and survival in Great Britain 1963 to 2002.
    MacCarthy A; Birch JM; Draper GJ; Hungerford JL; Kingston JE; Kroll ME; Stiller CA; Vincent TJ; Murphy MF
    Br J Ophthalmol; 2009 Jan; 93(1):38-9. PubMed ID: 18838414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical manifestations and treatment of retinoblastoma in Kobe children's hospital for 16 years.
    Okimoto S; Nomura K
    J Pediatr Ophthalmol Strabismus; 2014 Jul; 51(4):222-9. PubMed ID: 24844394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of pathologic risk factors in postchemoreduced, enucleated specimens of advanced retinoblastomas in a developing country.
    Suryawanshi P; Ramadwar M; Dikshit R; Kane SV; Kurkure P; Banavali S; Viswanathan S
    Arch Pathol Lab Med; 2011 Aug; 135(8):1017-23. PubMed ID: 21809993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome, pathologic findings, and compliance in orbital retinoblastoma (International Retinoblastoma Staging System stage III) treated with neoadjuvant chemotherapy: a prospective study.
    Radhakrishnan V; Kashyap S; Pushker N; Sharma S; Pathy S; Mohanti BK; Vishnubhatla S; Ghose S; Bakhshi S
    Ophthalmology; 2012 Jul; 119(7):1470-7. PubMed ID: 22463820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.